Products | Biopsy Systems | February 02, 2016

Fusion Bx

Fusion Bx

Related Content

FDA Approves IDE Application to Initiate Trial for Treating Locally Recurrent Prostate Cancer
News | FDA
FDA Approves IDE Application to Initiate Trial for Treating Locally Recurrent Prostate Cancer

Dec. 02, 2025 — Alpha Tau Medical Ltd., the developer of the alpha-radiation cancer therapy Alpha DaRT, has announced ...

Time December 04, 2025
arrow
Raidium Debuts New AI-Native PACS Viewer
News | PACS
Raidium Debuts New AI-Native PACS Viewer

Dec. 1, 2025 — At RSNA 2025, Raidium is introducing its new AI-native PACS Viewer powered by Curia, the first Foundation ...

Time December 01, 2025
arrow
Researchers Develop Imaging Probe That Helps Track, Possibly Treat, Prostate Cancer 
News | Prostate Cancer
Researchers Develop Imaging Probe That Helps Track, Possibly Treat, Prostate Cancer 

Nov. 10, 2025 — Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a ...

Time November 11, 2025
arrow
Multimodal AI Shows No Evidence of Bias in Prostate Cancer Study
Feature
Multimodal AI Shows No Evidence of Bias in Prostate Cancer Study

A new study published in JCO Clinical Cancer Informatics tackles a critical challenge in cancer diagnostics: ensuring ...

Time July 01, 2025
arrow
Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted the filing of its New Drug Application (NDA) for TLX007-CDx
News | Radiopharmaceuticals and Tracers
FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
Avenda Health’s study, published in The Journal of Urology, solidifies the power of AI in oncology as a viable and accurate diagnostic tool
News | Artificial Intelligence
New Study Proves AI Enhances Physicians’ Ability to Identify Extent of Prostate Cancer with 84 Percent Accuracy

June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time June 17, 2024
arrow
Latest innovations in clinical cancer research discussed at American Society of Clinical Oncology (ASCO) Annual Meeting
News | Radiopharmaceuticals and Tracers
Shine Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
arrow
Penn Medicine will have a strong presence at the upcoming American Society of Clinical Oncology (ASCO) 2024 Annual Meeting.
News | Clinical Trials
Penn Medicine to Present Multiple Clinical Trial Results at 2024 ASCO Annual Meeting

May 30, 2024 — Researchers from Penn Medicine’s Abramson Cancer Center (ACC) and the Perelman School of Medicine at the ...

Time May 29, 2024
arrow
new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS
Feature | Radiation Oncology | By Melinda Taschetta-Millane
Advancements in Diagnostic Radiology Video Series with Robert L. Bard, MD, PC, DABR, FASLMS

In a new 3-part video series on advancements in diagnostic radiology with Robert L. Bard, MD, PC, DABR, FASLMS ...

Time April 10, 2024
arrow
With the addition of MIM Software, GE HealthCare aims to provide clinicians and healthcare systems with increasingly integrated and automated solutions
News | Radiology Business
GE HealthCare Closes MIM Software Acquisition

April 2, 2024 — Less than three months after signing an agreement to acquire MIM Software Inc., GE HealthCare ...

Time April 02, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now